论文部分内容阅读
目的:观察阿奇霉素治疗支原体性肺炎临床效果。方法:选取2014年12月至2015年12月该院收治的90例支原体性肺炎患者,将所有患者平均分为两组,各为45例。对照组采用红霉素治疗,观察组采用阿奇霉素治疗,对两组患者的治疗效果进行比较。结果:与对照组相比,观察组临床症状效果更为显著。对照组患者治疗效果显著的16例,治疗有效的20例,治疗无效9例,总有效率为80.0%;观察组患者治疗效果显著的20例,治疗有效的23例,治疗无效的2例,总有效率为95.6%,两组比较差异具有统计学意义(P<0.05),观察组患者的咳嗽缓解、肺部啰音消失、体温恢复时间明显短于对照组。结论:阿奇霉素治疗支原体性肺炎临床效果,改善了患者的肺部功能,提高了患者的生活质量,临床上值得推广。
Objective: To observe the clinical effect of azithromycin in the treatment of mycoplasma pneumonia. Methods: 90 patients with mycoplasmal pneumonia admitted from December 2014 to December 2015 in our hospital were selected. All patients were divided equally into two groups (45 in each). The control group was treated with erythromycin, and the observation group was treated with azithromycin. The therapeutic effects of the two groups were compared. Results: Compared with the control group, the clinical symptoms of the observation group were more significant. The control group of patients with significant treatment effect in 16 cases, 20 cases of effective treatment, 9 cases of ineffective treatment, the total effective rate was 80.0%; observation group of patients with significant treatment of 20 cases, 23 cases of effective treatment, 2 cases of ineffective treatment, The total effective rate was 95.6%. The difference between the two groups was statistically significant (P <0.05). The cough relief, pulmonary rales disappeared and body temperature recovery time in the observation group was significantly shorter than that in the control group. Conclusion: Azithromycin in the treatment of mycoplasma pneumonia clinical effect, improve the lung function of patients and improve the quality of life of patients, clinically worth promoting.